BioXcel Therapeutics Statistics
Total Valuation
BTAI has a market cap or net worth of $25.97 million. The enterprise value is $117.58 million.
| Market Cap | 25.97M |
| Enterprise Value | 117.58M |
Important Dates
The last earnings date was Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BTAI has 31.31 million shares outstanding. The number of shares has increased by 389.70% in one year.
| Current Share Class | 31.31M |
| Shares Outstanding | 31.31M |
| Shares Change (YoY) | +389.70% |
| Shares Change (QoQ) | +28.55% |
| Owned by Insiders (%) | 0.62% |
| Owned by Institutions (%) | 8.21% |
| Float | 24.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 33.42 |
| Forward PS | 9.99 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 156.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.21
| Current Ratio | 0.21 |
| Quick Ratio | 0.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.60 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -102.43% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 41.28% |
| Weighted Average Cost of Capital (WACC) | 11.65% |
| Revenue Per Employee | $25,586 |
| Profits Per Employee | -$2.44M |
| Employee Count | 29 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0.70 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.37% in the last 52 weeks. The beta is 0.29, so BTAI's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | -85.37% |
| 50-Day Moving Average | 1.02 |
| 200-Day Moving Average | 1.42 |
| Relative Strength Index (RSI) | 43.40 |
| Average Volume (20 Days) | 791,469 |
Short Selling Information
The latest short interest is 4.21 million, so 13.46% of the outstanding shares have been sold short.
| Short Interest | 4.21M |
| Short Previous Month | 4.04M |
| Short % of Shares Out | 13.46% |
| Short % of Float | 16.97% |
| Short Ratio (days to cover) | 3.19 |
Income Statement
In the last 12 months, BTAI had revenue of $742,000 and -$70.86 million in losses. Loss per share was -$3.15.
| Revenue | 742,000 |
| Gross Profit | 394,000 |
| Operating Income | -44.73M |
| Pretax Income | -70.86M |
| Net Income | -70.86M |
| EBITDA | -44.51M |
| EBIT | -44.73M |
| Loss Per Share | -$3.15 |
Balance Sheet
The company has $12.84 million in cash and $104.45 million in debt, with a net cash position of -$91.61 million or -$2.93 per share.
| Cash & Cash Equivalents | 12.84M |
| Total Debt | 104.45M |
| Net Cash | -91.61M |
| Net Cash Per Share | -$2.93 |
| Equity (Book Value) | -115.46M |
| Book Value Per Share | -3.69 |
| Working Capital | -108.45M |
Cash Flow
| Operating Cash Flow | -50.90M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 225,000 |
| Net Borrowing | -8.41M |
| Free Cash Flow | -50.90M |
| FCF Per Share | -$1.63 |
Margins
| Gross Margin | 53.10% |
| Operating Margin | -6,028.57% |
| Pretax Margin | -9,549.87% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BTAI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -389.70% |
| Shareholder Yield | -389.70% |
| Earnings Yield | -285.76% |
| FCF Yield | -205.28% |
Analyst Forecast
The average price target for BTAI is $18.33, which is 2,109.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $18.33 |
| Price Target Difference | 2,109.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 361.98% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 10, 2025. It was a reverse split with a ratio of 1:16.
| Last Split Date | Feb 10, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:16 |
Scores
BTAI has an Altman Z-Score of -45.8 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -45.8 |
| Piotroski F-Score | 3 |